BINEX Co., Ltd. (KOSDAQ:053030)
13,750
-140 (-1.01%)
Jan 19, 2026, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 437.91 billion as of January 16, 2026. Its market cap has decreased by -24.49% in one year.
Market Cap
437.91B
Enterprise Value
514.05B
Revenue
165.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,750.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 437.91B, an increase of 1,631.81%. That is a compound annual growth rate of 12.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 437.91B | -8.21% |
| Dec 30, 2025 | 477.08B | -18.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |